Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions

Por Catteau, A, Xu, C-F, Brown, M A, Hodgson, S, Greenman, J, Mathew, C G, Dunning, A M, Solomon, E
Publicado em 1999

Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms(†)

Por Motzer, R. J., Johnson, T., Choueiri, T. K., Deen, K. C., Xue, Z., Pandite, L. N., Carpenter, C., Xu, C. F.
Publicado no Ann Oncol (2013)

The first linkage disequilibrium (LD) maps: Delineation of hot and cold blocks by diplotype analysis

Por Maniatis, N., Collins, A., Xu, C.-F., McCarthy, L. C., Hewett, D. R., Tapper, W., Ennis, S., Ke, X., Morton, N. E.
Publicado em 2002

Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children.

Por Xu, C F, Nanjee, M N, Savill, J, Talmud, P J, Angelico, F, Del Ben, M, Antonini, R, Mazzarella, B, Miller, N, Humphries, S E
Publicado em 1990

Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism

Por Xu, C-F, Reck, B H, Xue, Z, Huang, L, Baker, K L, Chen, M, Chen, E P, Ellens, H E, Mooser, V E, Cardon, L R, Spraggs, C F, Pandite, L
Publicado em 2010

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

Por Xu, C-F, Johnson, T, Garcia-Donas, J, Choueiri, T K, Sternberg, C N, Davis, I D, Bing, N, Deen, K C, Xue, Z, McCann, L, Esteban, E, Whittaker, J C, Spraggs, C F, Rodríguez-Antona, C, Pandite, L N, Motzer, R J
Publicado no Br J Cancer (2015)